NASDAQ OMX

Zinpro Corporation Announces Executive Leadership Changes

13.6.2017 18:53 | NASDAQ OMX

Dela

Anderson Promotes Scrimgeour to President & CEO, and Sheffer Joins Company as COO

EDEN PRAIRIE, Minn., June 13, 2017 (GLOBE NEWSWIRE) -- Zinpro Corporation announces that its owner, Michael D. Anderson, has promoted William Scrimgeour to be the company's next president and CEO. The transfer in CEO responsibilities to Scrimgeour will allow Anderson to concentrate more time and energy on his role as chairman of the board of directors. Anderson has held his positions as CEO and board of directors chairman for Zinpro Corporation since May, 1992.

The change in responsibilities will enable Anderson to more effectively lead the board of directors to set the company's future course and to provide strategic direction as the company continues to expand globally. "In the next five years, we anticipate our company's growth to increase rapidly worldwide, and we need to not only enhance our efforts in areas that will count most, but also add to our leadership team as we prepare for the future," says Anderson. "Handing off my CEO responsibilities will also allow me to concentrate more on how to expand the scope of our company's positive global impact, both on animals and people."

Anderson's successful tenure as CEO is marked by many accomplishments since taking on the role from his father and founder, Dean Anderson. Over the past 25 years, Michael Anderson has led the company to develop and launch more than 75 new products, to expand sales into 60 additional countries, to build three manufacturing facilities and to establish nine international subsidiaries and two new business ventures. In addition, he has guided the expansion of Zinpro Corporation into a leading global exporter of Performance Minerals®.

Scrimgeour takes on his new position as president and CEO, having previously served Zinpro Corporation as president and Chief Operating Officer (COO) since 2008. "Over the last nine years, Bill has excelled in overseeing all company departments and managing day-to-day operations," says Anderson. "I'm confident Bill will be instrumental in helping Zinpro to continue to meet the demand from an ever-increasing global customer base who desires our products and services to improve animal wellness and performance."

With Scrimgeour taking on the position of CEO, the company also announces that Rob Sheffer has joined Zinpro Corporation as its new COO. Sheffer comes to Zinpro with more than 25 years of leadership experience - most of it with a global animal nutrition company. Sheffer's wide-ranging leadership experience includes positions as president and CEO, group director, managing director, regional sales leader and branch manager. He also served as board chair for the American Feed Industry Association from 2015-2016.

"Rob has a proven track record for developing, motivating and inspiring teams to achieve business growth, including growth in global markets," says Scrimgeour. "I'm very pleased to welcome him to Zinpro to be our next COO. His extensive leadership experience in the feed and animal nutrition industries will serve him well, and Zinpro well, as our company continues to expand worldwide."

As the industry leader in trace mineral nutrition for livestock and poultry, Zinpro is committed to delivering the technical expertise, products and educational tools needed to help customers improve the performance and profitability of their operations.

About Zinpro Corporation

More than 45 years ago, Zinpro Corporation pioneered the research and development of Performance Minerals®. As a family-owned, privately-held company, Zinpro Corporation's steady growth has come as a result of quality products, quality people and a focus on one thing: performance trace minerals for exceptional animal nutrition. Today, the company has regional sales offices located in nine countries and markets its products in more than 70 countries worldwide. For more information, visit zinpro.com, or call +1 952-983-4000.

Performance Minerals® is a registered trademark of Zinpro Corporation. ©2017 Zinpro Corp. All rights reserved.

For more information, contact:
John Pocock
Corporate Communications Specialist
Zinpro Corporation
+1 952-983-3937
jpocock@zinpro.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Zinpro Corporation via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste nyheterna från NASDAQ OMX

Forterra Announces Second Quarter 2017 Earnings Schedule27.7.2017 22:30Pressmeddelande

IRVING, Texas, July 27, 2017 (GLOBE NEWSWIRE) -- Forterra, Inc. ("Forterra") (Nasdaq:FRTA) plans to release second quarter 2017 financial results before the market open on Thursday, August 10, 2017.  A conference call to review financial results will also be held on Thursday, August 10, 2017 at 8:30 a.m. Eastern time (7:30 a.m. Central).  Hosting the call will be Jeff Bradley, Chief Executive Officer, and Matt Brown, Executive Vice President and Chief Financial Officer. CONFERENCE CALL AND WEBCAST DETAILS Webcast Information Event: Q2 2017 Forterra, Inc. Earnings Call Date: Thursday, August 10, 2017 Time: 8:30 a.m. Eastern Time (7:30 a.m. Central) Webcast: http://edge.media-server.com/m/p/uxphuyzt Conference Call Information U.S.: 1-574-990-1396 Toll-Free: 1-844-498-0572 Parti

TGS Q2 2017 webcast and teleconference27.7.2017 18:14Pressmeddelande

ASKER, Norway, July 27, 2017 (GLOBE NEWSWIRE) -- TGS will release its Q2 2017 results at approximately 07:00 CEST on 3 August 2017. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 CEST at the Hotel Continental, Stortingsgata 24/26 in Oslo, Norway. The presentation is open to the public and can be followed live on the internet at www.tgs.com. The slides from the presentation will also be available in PDF format at both the TGS and Oslo Stock Exchange websites. CEO Kristian Johansen and CFO Sven Børre Larsen will host a conference call on 3 August 2017 at 15:00 CEST (09:00 EDT). Attendees may want to call 5-10 minutes before to ensure registration and access. Norwegian attendees are invited to call + 800 51084 or + 47 2100 2610 International attendees are invited to call 0800 358 6377 or + 44 (0)330 336 9105 US attendees are invited to call +1 866-

Vistajet Launches New Digital Platforms as Growth Accelerates in China27.7.2017 14:36Pressmeddelande

VistaJet grows team and launches Chinese website owing to passenger demand VistaJet VistaJet Challenger 850  VistaJet Ltd For the six months to 30th June 2017: Program Membership sales increase globally by a record 57% as customer retention hits 91% across all regions 12% year-on-year increase on passenger departures from China 100% customer renewal rate in Greater China in the first half of 2017 VistaJet Chinese website launched at www.vistajet.cn HONG KONG, July 27, 2017 (GLOBE NEWSWIRE) -- VistaJet continues to build on its China growth and demonstrates a commitment to the region by expanding its team and launching

Minerva Neurosciences to Report Second Quarter 2017 Financial Results and Business Updates on August 3, 201727.7.2017 14:30Pressmeddelande

Management to host conference call WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the second quarter of 2017 on Thursday, August 3, 2017.  The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates.  The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 53086270.  A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com.  The archived webcast will be available on the Company's website beginning approximately two hours after

Vertiv Sells ASCO® to Schneider Electric27.7.2017 14:22Pressmeddelande

Sale enables greater focus on core business COLUMBUS, Ohio, July 27, 2017 (GLOBE NEWSWIRE) -- Vertiv, formerly Emerson Network Power, today announced plans to sell its ASCO® business as it continues to sharpen its focus on the digital critical infrastructure space. The $1.25 billion sale to Schneider Electric allows Vertiv to apply additional resources toward business and technological advancements in its core data center, telecommunications and commercial and industrial markets. As Vertiv has repositioned itself after being sold to Platinum Equity in November 2016, it became clear that ASCO's strengths in the automatic transfer switch arena fell outside the new organization's more focused strategy, said Vertiv CEO Rob Johnson. "This sale is a significant step forward in our evolution as the premier provider of digital critical infrastructure solutions," Johnson said. "This is consistent with our strategy of focus

TESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in Japan27.7.2017 13:00Pressmeddelande

-   Takeda's Rights Include all Potential Indications for Niraparib in Japan and Rights Excluding Prostate Cancer in South Korea, Taiwan, Russia and Australia -   TESARO to Receive $100 Million Upfront Payment and is Eligible for Future Regulatory and Commercial Milestones, Plus Royalties WALTHAM, Mass. and OSAKA, Japan, July 27, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced an exclusive licensing agreement for the commercialization and clinical development of niraparib, a novel poly ADP-ribose polymerase (PARP) inhibitor. This agreement includes the development of niraparib for the treatment of all tumor types in Japan, and all tumor types excluding prostate cancer in South Korea, Taiwan, Russia and Australia. Niraparib, first marketed in the U.S. in April under the brand name ZEJULA(TM), has quickly

I vårt nyhetsrum kan du läsa de senaste nyheterna, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt nyhetsrum